EULIR, a protein whose acronym stands for Endoplasmic Reticulum Unfolded Protein Response Inhibitory Regulator, is a key component of the unfolded protein response (UPR) pathway, a cellular mechanism that maintains protein homeostasis in the endoplasmic reticulum (ER). The UPR is activated in response to ER stress, which occurs when unfolded or misfolded proteins accumulate in the ER lumen, leading to cellular dysfunction and apoptosis. EULIR acts as a negative regulator of the UPR, modulating the activity of key signaling pathways involved in ER stress response. By inhibiting the UPR, EULIR helps hinder excessive activation of ER stress pathways, thereby promoting cell survival and maintaining cellular homeostasis under stress conditions.
The inhibition of EULIR typically involves disrupting its interactions with other proteins or interfering with its functional activity within the UPR pathway. Several mechanisms can be employed to inhibit EULIR function, including the blockade of protein-protein interactions essential for EULIR-mediated inhibition of the UPR. Additionally, small molecule inhibitors or genetic approaches may be utilized to target EULIR directly, thereby impairing its ability to suppress the UPR. By inhibiting EULIR, researchers aim to activate the UPR pathway, which may have implications in diseases associated with ER stress, such as neurodegenerative disorders, cancer, and metabolic diseases. Understanding the mechanisms of EULIR inhibition provides valuable insights into the regulation of ER stress response.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a peptide aldehyde that inhibits proteasome and ubiquitin-related enzymes, potentially reducing the degradation of proteins ubiquitinated by HECTD1. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Lactacystin is a naturally occurring compound that irreversibly binds to and inhibits proteasomal activity, indirectly affecting the turnover of proteins modified by HECTD1. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Pyr-41 is a selective inhibitor of ubiquitin-activating enzyme E1, potentially limiting the ubiquitination process in which HECTD1 participates. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
MLN4924 inhibits the NEDD8-activating enzyme, which is crucial for activating E3 ubiquitin-protein ligases like HECTD1, possibly impacting its function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a dipeptide boronic acid analog that inhibits the 26S proteasome, potentially affecting the degradation of HECTD1-tagged proteins. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin is a natural product that selectively inhibits proteasome activity, which could influence HECTD1-related ubiquitination processes. | ||||||
IU1 | 314245-33-5 | sc-361215 sc-361215A sc-361215B | 10 mg 50 mg 100 mg | $138.00 $607.00 $866.00 | 2 | |
IU1 is a small molecule that inhibits the deubiquitinase USP14, potentially affecting the deubiquitination process of substrates targeted by HECTD1. | ||||||
Thiostrepton | 1393-48-2 | sc-203412 sc-203412A | 1 g 5 g | $117.00 $423.00 | 10 | |
Thiostrepton is a thiazole antibiotic that inhibits proteasome function and can affect the ubiquitin-proteasome system, indirectly affecting HECTD1. | ||||||